60 Degrees Pharmaceuticals (SXTP) EPS (Basic) (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly EPS (Basic) of -$1.21 for Q1 2026, up 80.61% year-over-year from -$0.67 in Q1 2025, and up 17.13% quarter-over-quarter from -$1.46 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) EPS (Basic) (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported EPS (Basic) for 5 consecutive years, with -$1.21 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 80.61% year-over-year to -$1.21; the TTM figure through Mar 2026 stood at -$4.13 (up 87.68% YoY), while the FY2025 annual figure was -$10.31, up 86.1% from the prior year.
- EPS (Basic) grew to -$1.21 in Q1 2026 per SXTP's latest filing, from -$1.46 in the prior quarter.
- Across five years, EPS (Basic) topped out at $184.59 in Q3 2023 and bottomed at -$336.79 in Q2 2023.
- Historically, EPS (Basic) has averaged -$75.87 across 5 years, with a median of -$18.89 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 226.26% — and 2025, when it slumped 185.37%.
- 60 Degrees Pharmaceuticals' EPS (Basic) stood at -$167.95 in 2022, then gained by 25.05% to -$125.89 in 2023, then jumped by 84.76% to -$19.18 in 2024, then soared by 92.38% to -$1.46 in 2025, then climbed by 17.13% to -$1.21 in 2026.
- Business Quant data shows SXTP's EPS (Basic) at -$1.21 in Q1 2026, -$1.46 in Q4 2025, and -$2.52 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 | -0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21 |
| Dec 31, 2025 | -1.46 |
| Sep 30, 2025 | -2.52 |
| Jun 30, 2025 | -4.71 |
| Mar 31, 2025 | -6.25 |
| Dec 31, 2024 | -19.18 |
| Sep 30, 2024 | -18.60 |
| Jun 30, 2024 | -84.50 |
| Mar 31, 2024 | 7.32 |
| Dec 31, 2023 | -125.89 |
| Sep 30, 2023 | 184.59 |
| Jun 30, 2023 | -336.79 |
| Mar 31, 2023 | -270.97 |
| Dec 31, 2022 | -167.95 |
| Sep 30, 2022 | -146.20 |
| Jun 30, 2022 | -219.64 |